Form 4: Medtronic Executive Sells Shares

Medtronic plc executive Harry Skip Kiil reported the sale of company shares on June 8, 2026, totaling 4,189 ordinary shares.

Summary

• Harry Skip Kiil, EVP & President Cardiovascular at Medtronic plc, reported a disposition of company stock.
• The transactions occurred on June 8, 2026.
• A total of 3,961 ordinary shares were sold at a price of $80.44 per share.
• An additional 228 ordinary shares were sold at a price of $80.45 per share.
• Following these transactions, Kiil beneficially owns 37,227 ordinary shares directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as slightly negative due to the sale of shares by a key executive, although the specific reasons for the sale are not disclosed.

Negatives

• Executive Harry Skip Kiil sold a significant number of company shares.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report changes in beneficial ownership by insiders, are routine disclosures. While executive share sales can sometimes be interpreted negatively by the market, the context of the sale (e.g., diversification, pre-planned sales under Rule 10b5-1) is crucial for a complete understanding. This filing does not provide such context.

Stakeholder Impact

• Shareholders may view the executive's sale of shares as a potential negative signal, although the reasons for the sale are not specified in the filing.

Key Dates

Recommendation

This filing reports a routine insider transaction (share sale) without providing additional context on the company's performance or future outlook. Therefore, it does not provide sufficient information to warrant a buy or sell recommendation, suggesting a 'hold' stance based solely on this disclosure.

Keywords

Medtronic, MDT, Form 4, insider trading, share sale, executive compensation, Cardiovascular